NOVOTECH IS A LEADING REGIONAL FULL-SERVICE CONTRACT RESEARCH ORGANIZATION (CRO) IN ASIA-PACIFIC PROVIDING CLINICAL DEVELOPMENT SERVICES ACROSS ALL CLINICAL TRIAL PHASES AND THERAPEUTIC AREAS AND GLOBAL PRODUCT DEVELOPMENT AND REGULATORY AFFAIRS CONSULTING THROUGH OUR IN-HOUSE BIODESK TEAM.
Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, Novotech and PPC. Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies.
Novotech has offices in 11 geographies across the region, and site partnerships with key medical institutions.
We provide clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety solutions, central lab services, report write-up to ICH requirements, project and vendor management.
Recently awarded the Frost & Sullivan 2020 Frost & Sullivan Asia-Pacific CRO Company of the Year, Novotech has also received several workplace and culture awards.
Working in a fast paced and adaptable environment, we set a high benchmark for clinical trial operations by listening carefully, allocating Asia Pacific’s best talent, and leveraging best in class platforms, technology, systems and processes to achieve our client’s clinical program milestones and ultimately improve patient lives.
Our people are critical in meeting organisational and client’s objectives and we place a strong emphasis on creating an inclusive, collaborative, transparent and collegiate work environment where everyone is supported to learn, grow and prosper.
We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.
Novotech has offices in 11 locations across the region, and site partnerships with major health institutions.
Novotech named as one the Best Companies to Work for in Asia 2021
Taipei, 7 September 2021
John Moller, Novotech CEO, signs the #IStandForRespect pledge, joining over 220 CEOs
Media Release 27 August 2021
Novotech Certified as a Great Workplace by Global Authority on Workplace Culture for Second Consecutive Year
Sydney - Australia – Novotech, the largest biotech specialist CRO in the Asia-Pacific region, has again been certified a